bispecific antibodies to engage vγ9vδ2-t cells for cancer immunotherapy
Published 2 years ago • 607 plays • Length 30:36Download video MP4
Download video MP3
Similar videos
-
3:53
bispecific antibodies in cancer immunotherapy
-
3:00
drawn to science | t-cell bispecific antibodies
-
49:07
a mucin 16 bispecific t cell-engaging antibody for the treatment of ovarian cancer
-
4:17
understanding bispecific antibody immunotherapy for cancer treatment
-
4:01
what are the differences between car t-cell therapy and bispecific antibodies?
-
1:15:12
innovations from the therapeutics antibody space: obligate bispecific antibodies & t cell engagers
-
14:00
what are bispecific antibodies?
-
1:38
bispecific antibodies, technics use in immunotherapy
-
4:26
what are bispecific antibodies?
-
4:45
bispecifics part 2: monoclonal and bispecific antibodies
-
45:42
what you need to know about bispecific antibody immunotherapy
-
1:26
moffitt medical minute (ep. 43) - bispecific antibodies (bsabs) in cancer treatment
-
0:55
what are bispecific antibodies?
-
23:13
bispecific antibodies in multiple myeloma | dana-farber cancer institute
-
2:11
bispecific antibodies enable synthetic agonistic receptor t-cell therapy in melanoma
-
6:09
bispecific antibodies | high impact topic (hit)
-
0:25
how bispecific antibodies work
-
3:28
bispecific antibodies in lung cancer
-
57:20
know your myeloma immunotherapy: bispecific antibodies with dr. cesar rodriguez